Dermira_Logo_RGB_R4V2_M01.jpg
Dermira Presents Data From DRM01 Phase 2a Trial at European Academy of Dermatology and Venereology
07 oct. 2015 07h30 HE | Dermira, Inc.
MENLO PARK, Calif., Oct. 7, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira_Logo_RGB_R4V2_M01.jpg
Dermira Announces Poster Presentation on DRM01 in Acne at World Congress of Dermatology
02 juin 2015 07h30 HE | Dermira, Inc.
MENLO PARK, Calif., June 2, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira_Logo_RGB_R4V2_M01.jpg
Clinical Data for Dermira's DRM01 Acne Program Presented at Dermatology Meeting
23 mars 2015 07h00 HE | Dermira, Inc.
MENLO PARK, Calif., March 23, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...